Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain

被引:55
|
作者
Burgar, HR [1 ]
Burns, HD [1 ]
Elsden, JL [1 ]
Lalioti, MD [1 ]
Heath, JK [1 ]
机构
[1] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
关键词
D O I
10.1074/jbc.M107785200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibroblast growth factor receptors (FGFRs) are a family of transmembrane tyrosine kinases involved in signaling via interactions with the family of fibroblast growth factors. Alternative splicing of the juxtamembrane region of FGFR1-3 leads to the inclusion or exclusion of two amino acids, valine and threonine, the VT site. The presence or absence of VT (VT + or VT -, respectively) affects the signaling potential of the receptor. The VT+ receptor isoform is required for Erk2 phosphorylation, a component of the mitogen-activated protein kinase signaling pathway. FRS2 is an adaptor protein that links FGFRs to the mitogen-activated protein kinase signaling pathway. FRS2 interacts with a region of the juxtamembrane domain of FGFR1 that includes the alternatively spliced VT site. We investigated the interaction of FRS2 with murine Fgfr1 juxtamembrane domain. We showed the alternatively spliced VT motif, at the juxtamembrane domain of Fgfr1 is required for FRS2 interaction with Fgfr1. Activation of signaling pathways from FRS2 is likely to be regulated by controlling the Fgfr1/FRS2 interaction through alternative splicing of the VT motif of Fgfr1.
引用
收藏
页码:4018 / 4023
页数:6
相关论文
共 50 条
  • [1] Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2α (FRS2α) but not FRS2β to the receptor
    Zhang, Yongyou
    McKeehan, Kerstin
    Lin, Yongshun
    Zhang, Jue
    Wang, Fen
    [J]. MOLECULAR ENDOCRINOLOGY, 2008, 22 (01) : 167 - 175
  • [2] Ureteric Morphogenesis Requires Fgfr1 and Fgfr2/Frs2α Signaling in the Metanephric Mesenchyme
    Sims-Lucas, Sunder
    Di Giovanni, Valeria
    Schaefer, Caitlin
    Cusack, Brian
    Eswarakumar, Veraragavan P.
    Bates, Carlton M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (04): : 607 - 617
  • [3] MAb Against Fibroblast Growth Factor Receptor 1 (FGFR1)
    Filonenko, Valeriy
    [J]. HYBRIDOMA, 2009, 28 (04): : 302 - 302
  • [4] Caenorhabditis elegans Fibroblast Growth Factor Receptor Signaling Can Occur Independently of the Multi-Substrate Adaptor FRS2
    Lo, Te-Wen
    Bennett, Daniel C.
    Goodman, S. Jay
    Stern, Michael J.
    [J]. GENETICS, 2010, 185 (02) : 537 - U229
  • [5] Sef inhibits fibroblast growth factor receptor signaling by inhibiting tyrosine phosphorylation of FRS2
    Yang, X
    Kovalenko, D
    Xu, J
    Friesel, R
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 15A - 15A
  • [6] Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development
    Hoch, RV
    Soriano, P
    [J]. DEVELOPMENT, 2006, 133 (04): : 663 - 673
  • [7] New intronic Fibroblast Growth Factor Receptor 1 (FGFR1) mutation leading to disrupted splicing and Kallmann syndrome
    Kansakoski, J.
    Vaaralahti, K.
    Raivio, T.
    [J]. HUMAN REPRODUCTION, 2018, 33 (02) : 328 - 330
  • [8] Fibroblast growth factor receptor 1 (Fgfr1) participates in postnatal interneuron development
    Smith, K. M.
    Maragnoli, M. E.
    Phull, P. M.
    Tran, K. M.
    Vaccarino, F. M.
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2010, 28 (08) : 698 - 698
  • [9] Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins
    Gotoh, Noriko
    [J]. CANCER SCIENCE, 2008, 99 (07) : 1319 - 1325
  • [10] Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors
    Tajima, Shogo
    Fukayama, Masashi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 9422 - 9427